Dose Escalation and Treatment Patterns of Advanced Therapies Used to Treat Ulcerative Colitis: A Retrospective Database Analysis in the United States

被引：0
|
作者：
Smith, Timothy W. [1 ]
DiBonaventura, Marco [1 ]
Gruben, David [2 ]
Bargo, Danielle [1 ]
Salese, Leonardo [3 ]
Quirk, Daniel [3 ]
机构：
[1] Pfizer Inc, New York, NY USA
[2] Pfizer Inc, Groton, CT 06340 USA
[3] Pfizer Inc, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
622
引用
收藏
页码：S352 / S352
页数：1
相关论文
共 50 条
  • [31] Real-World Treatment Persistence with Vedolizumab in Crohn's Disease and Ulcerative Colitis Patients in the United States (US): A Retrospective Analysis Using the Optum Research Database
    Demuth, Dirk
    Patel, Haridarshan
    Chastek, Benjamin
    Lee, Brekke
    Khalid, Javaria Mona
    Null, Kyle D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S324 - S324
  • [32] TREATMENT PATTERNS OF BIOLOGIC AGENTS IN ULCERATIVE COLITIS: A POOLED STUDY OF THREE UNITED STATES CLAIM DATABASES
    Sah, Janvi
    Teeple, Amanda M.
    Muser, Erik
    Gutierrez, Cynthia
    Adams, Christopher
    Dassopoulos, Themistocles
    GASTROENTEROLOGY, 2021, 160 (06) : S697 - S697
  • [33] Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States
    Zhdanava, Maryia
    Zhao, Ruizhi
    Manceur, Ameur M.
    Kachroo, Sumesh
    Lefebvre, Patrick
    Pilon, Dominic
    CROHNS & COLITIS 360, 2023, 5 (03)
  • [34] Predictors and outcomes of ustekinumab dose escalation to every 4 or every 6 weeks in ulcerative colitis: a multicenter cohort study in the United States
    Dalal, R.
    Esckilsen, S.
    Barnes, E.
    Pruce, J.
    Marcus, J.
    Allegretti, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S296 - S298
  • [35] A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis
    Cichewicz, Allie
    Tencer, Tom
    Gupte-Singh, Komal
    Egodage, Sonya
    Burnett, Heather
    Kumar, Jinender
    ADVANCES IN THERAPY, 2023, 40 (05) : 2116 - 2146
  • [36] A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis
    Allie Cichewicz
    Tom Tencer
    Komal Gupte-Singh
    Sonya Egodage
    Heather Burnett
    Jinender Kumar
    Advances in Therapy, 2023, 40 : 2116 - 2146
  • [37] Improved Adherence and Persistence With Once-Daily Lialda® Therapy for Ulcerative Colitis in the United States: Retrospective Analysis of a Multi-plan Claims Database
    Yen, Linnette
    Klingman, David
    Hodgkins, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S429 - S429
  • [38] Comorbidities, infections and treatment patterns in psoriasis patients: A retrospective analysis of a large United States electronic health record database
    Varsos, Georgios
    Peyerl, Fred W.
    Shen, Meng
    Lodaya, Kunal
    Gannu, Laxmi
    Shenoy, Apeksha
    Hayashida, David K.
    D'Souza, Fabian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 269 - 270
  • [39] TREATMENT PATTERNS AND ASSOCIATED OUTCOMES IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS IN THE UNITED STATES: A SYSTEMATIC REVIEW
    Siegel, Corey A.
    Seigel, Lauren
    Achrafie, Lia
    Singh, Harpreet
    Kochoedo, Maryse
    Constantin, Joelle
    Gupte-Singh, Komal
    GASTROENTEROLOGY, 2021, 160 (06) : S415 - S415
  • [40] Understanding Patient Preferences at the Time of Treatment Escalation to First Line Advanced Therapies in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries
    Schreiber, Stefan
    Walsh, Alissa
    Hur, Peter
    Panattoni, Laura
    Hauber, Brett
    Gahlon, Grace
    Coulter, Josh
    Wosik, Karolina
    Cappelleri, Joseph C.
    Land, Natalie
    Guo, Xiang
    Buisson, Anthony
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1057 - S1057
12345